Search results
People Moves: Weinberg Joins CRC Group
Insurance Journal· 17 hours agoCRC Group, headquartered in Honolulu, hired Andrew Weinberg as an underwriting team leader specializing in transportation. Weinberg is based in CRC's
CRC seeks feedback on licensing & permitting process
NJBIZ· 6 days agoNew Jersey Cannabis Regulatory Commission is seeking public feedback on its permitting and licensing process. License applicants and business operators...
Earnings call: CRC outlines merger benefits and Q1 financials By Investing.com
Investing.com· 7 days agoCalifornia Resources Corporation (NYSE:CRC), a prominent energy producer in California, held its Q1...
California Resources Corporation (NYSE:CRC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoCalifornia Resources Corporation (NYSE:CRC) Q1 2024 Earnings Call Transcript May 8, 2024 California...
California Resources Corp (CRC) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
GuruFocus.com via Yahoo Finance· 6 days agoAmidst operational hurdles, CRC demonstrates robust financial health and strategic foresight in shareholder value maximization and sustainable practices.
California Resources (NYSE:CRC) Price Target Raised to $64.00 at Mizuho
ETF DAILY NEWS· 2 days agoCalifornia Resources (NYSE:CRC – Free Report) had its target price lifted by Mizuho from $63.00 to $64.00 in a report released on Monday morning, Benzinga reports. Barclays ...
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 3 hours agoThe trial met its primary endpoint, with 34% of the 94 metastatic colorectal cancer (CRC) patients reaching a median progression-free survival of 6.9...
California Resources First Quarter 2024 Earnings: Misses Expectations
Simply Wall St. via Yahoo Finance· 7 days agoCalifornia Resources (NYSE:CRC) First Quarter 2024 Results Key Financial Results Revenue: US$525.0m...
People Moves: Torres Joins XPT Specialty; Brown & Riding Adds Visconti
Insurance Journal· 5 hours agoXPT Specialty, headquartered in Barre, Vermont, appointed Suzette Torres as vice president of...
Analyst Report: Guardant Health, Inc.
Morningstar Research via Yahoo Finance· 11 hours agoIn 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal ...
